- - - - - - Cambridge, Mass., Wednesday, June 11, 2020– Praxis Precision Medicines, a clinical-stage, genetic neuroscience company, today announced the promotion of Stuart Chaffee, Ph.D., to chief...
- - - - - - Cambridge, Mass., Wednesday, June 11, 2020– Praxis Precision Medicines, a clinical-stage, genetic neuroscience company, today announced the promotion of Stuart Chaffee, Ph.D., to chief...
Recent Comments